Fate Therapeutics Presents Updated Preliminary FT819 Data in Lupus Nephritis
Fate Therapeutics presented updated preliminary data for FT819 in active lupus nephritis at ASN Kidney Week 2026. The supplied body is truncated.
Fate Therapeutics presented updated preliminary data for FT819 in active lupus nephritis at ASN Kidney Week 2026. The supplied body is truncated.